Inhibitory effects of baicalin on orthotopic xenografts of colorectal cancer cells that are deficient in a mismatch repair gene in nude mice

International Journal of Colorectal Disease

Volumn 28, Issue 4, 2013, Pages 547-553

  Yang, Bo Lin ^a   Chen, Hong Jin ^a   Chen, Yu Gen ^a   Gu, Yun Fei ^a   Zhang, Shu Peng ^a   Lin, Qiu ^a   Sun, Yu ^b  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b Nanjing Origin Biosciences Inc   (China)

Author keywords

Baicalin; Colorectal cancer; Efficacy; Mismatch repair gene; Orthotopic transplantation model

Indexed keywords

BAICALIN; PROTEIN MLH1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER MORTALITY; CAUSE OF DEATH; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; HMLH1 GENE; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOLOGICAL PARAMETERS; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR VASCULAR DENSITY; TUMOR VOLUME; TUMOR XENOGRAFT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; COLORECTAL NEOPLASMS; DNA MISMATCH REPAIR; FLAVONOIDS; FLUORESCENCE; GREEN FLUORESCENT PROTEINS; HCT116 CELLS; HUMANS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NUCLEAR PROTEINS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84877875552     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1562-z     Document Type: Article

References (19)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90
2. Muller A, Fishel R (2002) Mismatch repair and the hereditary non-polyposis colorectal cancersyndrome (HNPCC). Cancer Invest 20:102-109
3. Perez-Cabornero L, Velasco E, Infante M, Sanz D, Lastra E et al (2009) A new strategy to screen MMR genes in lynch syndrome: HA-CAE, MLPA and RT-PCR. Eur J Cancer 45:1485-1493
4. Ribic CM, Sargent DJ et al (2003) Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349(3):247-257
5. Carethers JM, Smith EJ, Behling CA et al (2004) Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology 126(2):394-401
6. Burn J, Bishop T, Mecklin JP, Macrae F, Moslein G, Olschwang S (2008) Effect of aspirin or resistant starch on colorectal neoplasia in the lynch syndrome. N Engl J Med 359:2567-2578
7. Logan RFA, Grainge MJ, Shepherd VC, Armitage NC, Muir KR (2008) Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 134:29-38
8. Yang BL, Liu F, Gu YF, Jin HY, Liu XF (2008) Inhibitory effect of baicalin on a colonic LoVo cell line with a deficient mismatch repair gene and its mechanism. World Chin J Digestol 16(21):2376-2380
9. Liu XF, Jing HY, Ding YJ, Lu Y, Li L, Ding SQ et al (2007) Inhibitory effect of a Chinese herbal medicine with anti-mutation activity on a mismatch repair gene deficient colorectal cancer cell line. World Chin J Digestol 15(20):2201-2204
10. Yang M, Jiang P, Sun FX et al (1999) A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res 59(4):781-786
11. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. V.2.2011. http://www.nccn.org/professionals/ physician-gls/pdf/colon.pdf. Accessed Aug 2012
12. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer. V.2.2011. http://www.nccn.org/professionals/ physician-gls/pdf/rectal.pdf. Accessed Aug 2012
13. Taketo MM, Edelmann W (2009) Mouse models of colon cancer. Gastroenterology 136:780-798
14. Jin H, Yang Z, Wang J, Zhang S, Sun Y, Ding Y (2011) A superficial colon tumor model involving subcutaneous colon translocation and orthotopic transplantation of green fluorescent protein-expressing human colon tumor. Tumour Biol 32(2):391-397
15. Jin H, Liu X, Li VK, Ding Y, Yun S, Liu F et al (2009) A simple colostomy implantation model for evaluating colon cancer. Int J Colorectal Dis 24(1):41-47
16. Bibby MC (2004) Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer 40:852-857
17. Nucera C, Nehs MA, Mekel M et al (2009) A novel orthotopic mouse model of human anaplastic thyroid carcinoma. Thyroid 19(10):1077-1084
18. Acikaln MF, Oner L, Topeu L et al (2005) Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Dig Liver Dis 37(3):162-169
19. Carron CP, Meyer DM, Pegg JA et al (2006) A peptidomimetic antagonist of the integrin alpha(v) beta3 inhibits Leydig cell tumor growth and development of hypercalcemia of malignancy. Cancer Res 58(9):1930-1935